Items where authors include "Baurcha, A."

Proceedings Paper

Mainz, J.G., Zagoya, C., Polte, L. et al. (12 more authors) (2022) WS02.01 Abdominal symptoms significantly decline after 24 weeks of elexacaftor/tezacaftor/ivacaftor treatment: first results obtained with the cystic fibrosis-specific CFAbd-Score in Germany and the UK. In: Journal of Cystic Fibrosis. 45th European Cystic Fibrosis Conference, 08-11 Jun 2022, Rotterdam, The Netherlands. Elsevier .